XML 24 R9.htm IDEA: XBRL DOCUMENT v3.21.1
Financial Instruments and Fair Value
12 Months Ended
Jan. 31, 2021
Investments All Other Investments [Abstract]  
Financial Instruments and Fair Value

2. Financial Instruments and Fair Value

The Company invests a portion of its cash in debt securities that are denominated in United States dollars. The investment portfolio consists of money market funds, asset-backed securities, commercial paper, U.S. government securities and debt securities of corporations. All of the investments are classified as available-for-sale securities and reported at fair value in the consolidated balance sheets as follows:

 

 

 

As of January 31, 2021

 

 

 

Amortized Cost

 

 

Unrealized Gains

 

 

Unrealized Losses

 

 

Fair Value

 

 

 

(in thousands)

 

Money market funds

 

$

171

 

 

$

 

 

$

 

 

$

171

 

Commercial paper

 

 

66,181

 

 

 

 

 

 

 

 

 

66,181

 

Corporate bonds

 

 

102,108

 

 

 

980

 

 

 

(7

)

 

 

103,081

 

Asset-backed securities

 

 

15,740

 

 

 

164

 

 

 

 

 

 

15,904

 

U.S. government securities

 

 

29,383

 

 

 

82

 

 

 

 

 

 

29,465

 

Total cash equivalents and marketable debt securities

 

$

213,583

 

 

$

1,226

 

 

$

(7

)

 

$

214,802

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As of January 31, 2020

 

 

 

Amortized Cost

 

 

Unrealized Gains

 

 

Unrealized Losses

 

 

Fair Value

 

 

 

(in thousands)

 

Money market funds

 

$

8,284

 

 

$

 

 

$

 

 

$

8,284

 

Commercial paper

 

 

63,390

 

 

 

 

 

 

 

 

 

63,390

 

Corporate bonds

 

 

95,053

 

 

 

653

 

 

 

 

 

 

95,706

 

Asset-backed securities

 

 

23,062

 

 

 

69

 

 

 

(2

)

 

 

23,129

 

U.S. government securities

 

 

20,524

 

 

 

48

 

 

 

 

 

 

20,572

 

Total cash equivalents and marketable debt securities

 

$

210,313

 

 

$

770

 

 

$

(2

)

 

$

211,081

 

 

As of January 31, 2021, there were no debt securities with unrealized losses for more than twelve months.          

 

 

As of

 

 

 

January 31, 2021

 

 

January 31, 2020

 

 

 

(in thousands)

 

Included in cash equivalents

 

$

15,368

 

 

$

37,736

 

Included in marketable debt securities

 

 

199,434

 

 

 

173,345

 

Total cash equivalents and marketable debt securities

 

$

214,802

 

 

$

211,081

 

 

The contractual maturities of the investments at January 31, 2021 and 2020 were as follows:

 

 

 

As of

 

 

 

January 31, 2021

 

 

January 31, 2020

 

 

 

(in thousands)

 

Due within one year

 

$

135,899

 

 

$

146,267

 

Due within one to three years

 

 

78,903

 

 

 

64,814

 

Total cash equivalents and marketable debt securities

 

$

214,802

 

 

$

211,081

 

 

The unrealized gains and losses on the available-for-sale securities were primarily caused by fluctuations in market value and interest rates as a result of the economic environment. Upon adoption of ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, the Company estimates the expected losses at an individual security level whenever a security’s fair value is below its amortized cost basis using the discounted cash flow method. The credit-related portion of the loss is recognized in other income, net in the condensed consolidated statements of operations but is limited to the difference between the fair value and the amortized cost basis of the security, adjusted for accrued interest. The non-credit-related portion of the loss is recognized in accumulated other comprehensive income in the condensed consolidated balance sheets. The credit-related losses of the Company’s financial instruments were not material for the fiscal year ended January 31, 2021. The net amounts of unrealized gains and unrealized losses that are not credit-related are recognized in other comprehensive income.

The following fair value hierarchy is applied for disclosure of the inputs used to measure fair value. This hierarchy prioritizes the inputs into three broad levels as follows:

Level 1—Inputs are unadjusted quoted prices in active markets for identical assets or liabilities.

Level 2—Inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the assets or liabilities, either directly or indirectly through market corroboration, for substantially the full term of the financial instruments.

Level 3—Unobservable inputs based on the Company’s own assumptions used to measure assets and liabilities at fair value. The inputs require significant management judgment or estimation.

The Company measures the fair value of money market funds using quoted prices in active markets for identical assets and classifies them within Level 1. The fair value of the Company’s investments in other debt securities are obtained based on quoted prices for similar assets in active markets and are classified within Level 2.

The following tables present the fair value of the financial instruments measured on a recurring basis as of January 31, 2021 and 2020, respectively:

 

 

 

As of January 31, 2021

 

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

 

(in thousands)

 

Money market funds

 

$

171

 

 

$

171

 

 

 

 

 

 

 

 

 

Commercial paper

 

 

66,181

 

 

 

 

 

 

 

66,181

 

 

 

 

 

Corporate bonds

 

 

103,081

 

 

 

 

 

 

 

103,081

 

 

 

 

 

Asset-backed securities

 

 

15,904

 

 

 

 

 

 

 

15,904

 

 

 

 

 

U.S. government securities

 

 

29,465

 

 

 

 

 

 

 

29,465

 

 

 

 

 

Total cash equivalents and marketable debt securities

 

$

214,802

 

 

$

171

 

 

$

214,631

 

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As of January 31, 2020

 

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

 

(in thousands)

 

Money market funds

 

$

8,284

 

 

$

8,284

 

 

$

 

 

$

 

Commercial paper

 

 

63,390

 

 

 

 

 

 

63,390

 

 

 

 

Corporate bonds

 

 

95,706

 

 

 

 

 

 

95,706

 

 

 

 

Asset-backed securities

 

 

23,129

 

 

 

 

 

 

23,129

 

 

 

 

U.S. government securities

 

 

20,572

 

 

 

 

 

 

20,572

 

 

 

 

Total cash equivalents and marketable debt securities

 

$

211,081

 

 

$

8,284

 

 

$

202,797

 

 

$